Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Imraldi 40 mg solution for injection in pre-filled syringe (0.4 ml)

Active Ingredient:
adalimumab
Company:  
Biogen Biosimilars See contact details
ATC code: 
L04AB04
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Imraldi Patient Reminder Card

This card contains select important safety information that patients need to know before and during treatment with Imraldi.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Biogen Biosimilars
Company image
Address
5 Foundation Park, Roxborough Way, Maidenhead, Berkshire, SL6 3UD, UK
Telephone
+44 (0) 203 608 8622
Medical Information Direct Line
+44 (0) 203 608 8622
Medical Information e-mail
[email protected]
WWW
https://www.biogen.uk.com